Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification

Blood Coagul Fibrinolysis. 2005 Oct;16(7):461-4. doi: 10.1097/01.mbc.0000184739.35347.13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Humans
  • Middle Aged
  • Risk Factors
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / methods

Substances

  • Anticoagulants